With industry's blessing, FDA launches novel excipient review pilot program
The FDA on Tuesday launched a new pilot program that will initially review four novel excipients over two years, with an eye toward helping drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
